Notice of Annual General Meeting of Dignitana AB (publ)

The shareholders in Dignitana AB (publ), 556730-5346, ("Company") is hereby summoned to the Annual General Meeting held on Wednesday of the 15 May 2019 at 9.00 at the Company's premises, Traktorgränden 3, in Lund, Sweden.

Right to attend the general meeting and notification
Shareholders who wish to participate in the Annual General Meeting (“AGM”) must be included in the share register maintained by Euroclear Sweden AB on Thursday May 9, 2019 and register to attend the meeting by email to investorrelations@dignitana.com or by telephone +46-77-07 91 885 by no later than Thursday May 9 2019. The notification must state the full name of the shareholder, personal or corporate identity number, shareholding, address, daytime telephone number, and, where appropriate, the representative or number of assistants (not more than 2). The notification shall be accompanied, where appropriate, by proxies, powers of attorney, registration certificates and other documents of authorization.

Nominee-registered shares
Shareholders, whose shares are registered in the name of a bank or other nominee, must temporarily register their shares in their own name with Euroclear Sweden AB in order to be entitled to participate in the Annual General Meeting. Such registration, which normally is processed in a few days, must be completed no later than Thursday of the 9 May 2019 and must therefore be requested from the nominee well before this date.

The complete notice is available via the link here: https://dignitana.com/2019agm/

Company Contact

William Cronin, Chief Executive Officer, Dignitana AB  bill.cronin@dignitana.com +1 469 917 5555

Mikael Wahlgren, Deputy Managing Director, Dignitana AB  mikael.wahlgren@dignitana.com   +46 709 33 72 20

About Dignitana AB (publ)

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser.  Learn more at www.dignitana.se and www.dignicap.com.

Tags:

About Us

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Stockholm with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank AB, Certified Adviser, +46 (0) 8 463 83 00 certifiedadviser@penser.se www.penser.se Learn more at www.dignitana.se and www.dignicap.com.

Subscribe

Documents & Links